A Phase 2, Open-Label, Multi-Center, Randomized Trial to Demonstrate the Pharmacokinetics of LCP-Tacro Tablets Once Daily and Prograf Capsules Twice Daily in Adult De Novo Liver Transplant Patients
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Veloxis Pharmaceuticals
- 03 Jul 2012 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 03 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jan 2011 Top-line, long-term safety and efficacy data are positive, according to a LifeCycle Pharma media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History